The general meeting of the Investment Committee of China pharmaceutical promotion association was held in Beijing

Source: on the morning of May 18, 2018, China Pharmaceutical Innovation Promotion Association (hereinafter referred to as "China pharmaceutical innovation promotion association") pharmaceutical innovation investment professional committee (hereinafter referred to as "investment special committee") was successfully held in Beijing More than 90 people attended the meeting, including Jiang Jiandong, President of China pharmaceutical promotion association, song Ruilin, executive chairman, Tian Yuan, vice chairman, members and industry related persons Feng LAN, Secretary General of the China Association for the promotion of drugs, presided over the meeting and made a report on the work of the first special investment committee on behalf of Dr Du Ying, chairman and CEO of zaiding pharmaceutical In the past two years, the first Special Committee on investment has achieved the following important results: 1、 The annual brand event "China Pharmaceutical Innovation and investment conference" (hereinafter referred to as "Venture Capital Conference") of pharmaceutical innovation and investment industry was founded Two sessions of "Venture Capital Conference" have been successfully held, which has built a high-end cooperation platform for display and exchange between pharmaceutical innovation and investment industry, effectively promoting the docking and common development of Chinese pharmaceutical innovation and a variety of capitals 2、 Take the lead to assist the Hong Kong stock exchange to complete the biggest reform of listing system in 25 years - allow zero profit bio / life technology companies with a certain scale of capital market value / trading volume to be listed on the Hong Kong stock exchange In the consultation stage of the Hong Kong stock exchange, the Investment Committee led a group to visit and exchange views with the Hong Kong stock exchange for many times, and actively assisted the Hong Kong stock exchange to complete the reform of the listing system Secretary General Feng LAN made the report on the work of the first special committee for investment According to the relevant provisions of the management measures for the professional committee of China pharmaceutical innovation promotion association, the meeting deliberated and approved the list of the second members of the special committee for investment (68 members), and elected one chairman and 10 vice chairmen Tian Yuan, the founding partner of Yuanming capital, was elected as the second chairman of the investment special committee; Du Ying, the chairman and CEO of zaiding pharmaceutical, Li Kaijun, the managing partner of Lize capital, Zhu Jinqiao, the chairman of Yifeng venture capital, Chen Penghui, the founding partner of Boyuan capital, Liang yingyu, the managing partner of Qiming venture capital, Yi nuoqing, the partner of Gaoling capital, and Chu Huibin, the chief partner of Haijie investment , Cai Dajian, founder and chairman of gaotejia investment group, Lu Xiaobo, medical partner of Sequoia Capital China fund, and Yu Shixin, head of health industry business department of China Merchants Group, were elected as the second vice chairman of the investment special committee (the list of the second members of the investment special committee is attached) Dr Song Ruilin (left), President of the China Association for the promotion of drugs, director of the Institute of pharmaceutical research of the Chinese Academy of Medical Sciences, and executive chairman of the China Association for the promotion of drugs, took a photo with Tian Yuan (middle), the second chairman of the investment special committee, and expressed thanks for being elected as the second chairman of the investment special committee He highly affirmed the positive contribution of the first chairman Dr Du Ying in giving full play to the role of the investment committee and promoting the holding of the venture capital conference He said: the second investment committee will mainly do the following work: 1 We will do our best to hold the third Venture Capital Conference; 2 Set up the research group of "payment policy of innovative drug commercial insurance" of China pharmaceutical promotion association, and explore the path of commercial insurance to ensure the use of high value innovative drugs and reduce the burden of national basic medical insurance fund; 3 Regularly hold 3-4 innovation investment salons or conferences every year to promote investment institutions and drug research and development institutions of China pharmaceutical promotion association In depth exchanges and cooperation among member units Following the speech by Tian Yuan, chairman of the second session of the investment special committee, the first working meeting of the second session of the investment special committee was held The members discussed and reached an agreement on the key work to be carried out by the investment special committee 1、 To assist the representatives of the third (2018) China Pharmaceutical Innovation and investment conference to have a detailed discussion on the agenda, organization and theme setting of the third Venture Capital Conference In view of the current problems in drug R & D and investment in China, committee member Cheng Jianxin proposed that the third Venture Capital Conference should set up a special forum or satellite conference with the theme of "investment M & A (including cross-border M & A)", "commercial insurance supporting innovative drug R & D", which was unanimously agreed by the members and representatives attending the conference Everyone also expressed that they would actively participate in the preparatory work of the Venture Capital Conference and the relevant investment forum 2、 This paper discusses the selection method and standard of investment organization of "Dushu Lake Cup" pharmaceutical innovation brand selection, the members and representatives attending the meeting support "Dushu Lake Cup" pharmaceutical innovation brand selection "to add" most dynamic investment organization "award, and discusses the selection method and standard of investment organization, and puts forward constructive suggestions 3、 Dr Tian Yuan, chairman of the second session of the investment special committee, suggested that the investment special committee should be led by the vice chairman and hold small-scale innovative investment exchange activities every quarter, and determined the principle that the venue and catering expenses needed for the activities should be borne by the leading organization, and the participants' transportation and accommodation expenses should be borne by themselves The second vice chairman unit of the Investment Committee: Yifeng venture capital, gaotejia investment, Haijie investment and Boyuan capital actively applied to undertake the activities of the investment committee this year The new session of the Special Committee on investment has comprehensively improved the understanding of the members of the Special Committee on investment on the work of the special committee and innovated the working mode of the special committee, which is conducive to giving full play to the advantages of excellent professional investors in the field of medicine of the Special Committee on investment and the carrier platform role of connecting innovative enterprises and investment institutions, and to promoting the early and in-depth integration of pharmaceutical innovation projects and capital power Attachment to the meeting: list of members of the second investment special committee